Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: The TANTALUS® II for the Treatment of Type 2 Diabetes [NA]
Completed clinical trial evaluating TANTALUS II for the treatment of type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use [NA]
A completed clinical trial evaluating an electronic health record-based strategy to promote safe and appropriate drug use in patients with t…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Mechanisms and Reversibility of Heart Failure Associated With Diabetes
This completed trial investigates the mechanisms and potential reversibility of heart failure in people with type 2 diabetes.
-
CLINICAL_TRIALS research · 2016-09-21Clinical Trial Update: The Influence of Plaquenil/Hydroxychloroquine (HCQ) on Insulin Secretion [Phase 1, Phase 2]
This entry notes a Phase 1/2 clinical trial evaluating hydroxychloroquine (Plaquenil) and its effect on insulin secretion in individuals wit…
-
FDA approval · 2016-09-20FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for liraglutide by Teva Pharmaceuticals USA, Inc., indicating an approved modification to the produc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-09-20FDA Approved: INVOKAMET XR — Original Application (Janssen Pharmaceuticals, Inc.)
FDA approved INVOKAMET XR (canagliflozin and metformin hydrochloride) through an Original Application. It is indicated for the treatment of …
-
CLINICAL_TRIALS safety_alert · 2016-09-20Clinical Trial Update: Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments
An AstraZeneca-sponsored clinical trial update documents a risk of hospitalization for severe hypersensitivity reactions, including severe s…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Risk of Hospitalized Infections Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatment
A completed clinical trial assessed the risk of hospitalization for infections in patients with type 2 diabetes mellitus treated with oral a…
-
CLINICAL_TRIALS safety_alert · 2016-09-20Clinical Trial Update: Risk of Acute Liver Failure Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments
A clinical trial update discusses the risk of acute liver failure in patients with type 2 diabetes exposed to oral antidiabetic medications,…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Risk of Cardiovascular Events in Patients With Type 2 Diabetes Initiating Oral Antidiabetic Treatments
AstraZeneca reports the completion of a trial evaluating cardiovascular event risk in patients with Type 2 diabetes initiating oral antidiab…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Risk of Acute Kidney Injury Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments
A completed clinical trial update evaluating the risk of acute kidney injury in patients with Type 2 diabetes mellitus exposed to oral antid…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Effects of Acute Exercise on Acetylcarnitine Concentration in Endurance Trained and Untrained Subjects [NA]
A completed trial evaluating whether acute exercise changes acetylcarnitine concentrations in endurance-trained versus untrained individuals…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus [Phase 1]
This is a Phase 1 pharmacokinetic single-dose study of empagliflozin in children and adolescents with Type 2 diabetes mellitus, with results…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"
Clinical trial update on alogliptin tablets in combination therapy with thiazolidinediones for type 2 diabetes mellitus. The study status is…
-
CLINICAL_TRIALS research · 2016-09-16Clinical Trial Update: Whey Protein Effect on Glycaemic and Appetite Responses in T2D [NA]
A clinical trial update from Northumbria University examining the effect of whey protein on glycemic and appetite responses in individuals w…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Rosiglitazone on Microalbuminuria in Type 2 Diabetics [Phase 3]
A Phase 3 trial evaluating rosiglitazone for microalbuminuria in type 2 diabetes has completed. The provided excerpt does not include trial …
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes [Phase 2]
Phase 2 pediatric dose-finding study of linagliptin for type 2 diabetes completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin [Phase 4]
Phase 4 trial update evaluating rosiglitazone added to insulin in adults with Type 2 diabetes inadequately controlled on insulin; the study …
-
CLINICAL_TRIALS research · 2016-09-15Clinical Trial Update: Impact of a Sexology Consultation on Disease Control of Type 2 Male Diabetics With Erectile Dysfunction [NA]
Clinical trial update examining whether sexology consultation affects disease control in men with Type 2 diabetes mellitus and erectile dysf…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Low Glycemic Index Diet for Type 2 Diabetics [Phase 2]
A Phase 2 clinical trial evaluating the effects of a low glycemic index diet in individuals with Type 2 diabetes has been completed.
-
CLINICAL_TRIALS withdrawal · 2016-09-14Clinical Trial Update: An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner System [NA]
An open-label extension study for the EndoBarrier Gastrointestinal Liner System has been withdrawn from the trial.
-
CLINICAL_TRIALS research · 2016-09-14Clinical Trial Update: Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes [NA]
This document reports on an ongoing clinical trial evaluating the effect of sitagliptin on gut microbiota in patients newly diagnosed with T…
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Use of Canagliflozin in Conjunction With Insulin in a Real-world Setting
A completed real-world study evaluating the use of canagliflozin in combination with insulin for type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Patients and Care Providers Perspectives and Experience With Decision Aid Tool for Self-monitoring of Blood Glucose [NA]
This report summarizes the perspectives and experiences of patients and care providers with a decision aid tool for self-monitoring blood gl…
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment [Phase 4]
Phase 4 clinical trial update examining the interplay of Par-4 and the telomere-telomerase system in Type 2 diabetes patients. The study inv…